Skip to content
healthcare.dev
Get a free key

Buprenorphine and Naloxone

NDC 0121-2036, buprenorphine hydrochloride and naloxone hydrochloride, tablet, from PAI Holdings, LLC dba PAI Pharma.

Product NDC
0121-2036
Status
Listed
Labeler
PAI Holdings, LLC dba PAI Pharma
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204431
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0121-2036 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE8 mg/1
  • NALOXONE HYDROCHLORIDE2 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
0121-2036-300012120363030 TABLET in 1 BOTTLE, PLASTIC (0121-2036-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d5b011ef-f1be-47f2-8f8b-07553f36193c

  • NADAC price for package 00121203630

    GET /v1/drugs/nadac/00121203630

Use it

Look up 0121-2036 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0121-2036 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0121-2036. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.